There have been 50 recent insider transactions recorded for X4 Pharmaceuticals, Inc. (XFOR), including 34 buys and 12 sells. Total insider buying was valued at $16.94M and total insider selling at $474.36K.
Notable insiders with recent activity include Wyzga Michael S, Stewart Murray, De Craecker Francoise. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — XFOR
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-01-01 |
Wyzga Michael S |
Director |
RSU Award |
110,000 |
$4.00 |
$440K |
- |
| 2026-01-01 |
Stewart Murray |
Director |
RSU Award |
110,000 |
$4.00 |
$440K |
- |
| 2026-01-01 |
De Craecker Francoise |
Director |
RSU Award |
110,000 |
$4.00 |
$440K |
- |
| 2026-01-01 |
Bridger Gary |
Director |
RSU Award |
110,000 |
$4.00 |
$440K |
- |
| 2025-10-29 |
Kirske David |
Chief Financial Officer |
RSU Award |
1,552,769 |
$1.42 |
$2.2M |
1,552,769 |
| 2025-10-29 |
Craig Adam R |
Executive Chairman |
RSU Award |
2,329,154 |
$1.42 |
$3.31M |
2,329,154 |
| 2025-10-29 |
Volpone John |
President |
RSU Award |
2,329,154 |
$1.42 |
$3.31M |
2,329,154 |
| 2025-10-23 |
Craig Adam R |
Executive Chairman |
Informative Buy |
86,206 |
$2.90 |
$250K |
376,087 |
| 2025-08-14 |
Kirske David |
Chief Financial Officer |
RSU Award |
193,254 |
- |
- |
193,254 |
| 2025-08-14 |
Craig Adam R |
Executive Chairman |
RSU Award |
289,881 |
- |
- |
289,881 |
| 2025-08-14 |
Volpone John |
President |
RSU Award |
289,881 |
- |
- |
289,881 |
| 2025-08-12 |
Kirske David |
Officer |
Unknown |
- |
- |
- |
- |
| 2025-08-12 |
Kirske David |
Chief Financial Officer |
RSU Award |
1,073,249 |
$1.42 |
$1.52M |
1,073,249 |
| 2025-08-12 |
Craig Adam R |
Executive Chairman |
Unknown |
- |
- |
- |
- |
| 2025-08-12 |
Craig Adam R |
Executive Chairman |
RSU Award |
1,609,873 |
$1.42 |
$2.29M |
1,609,873 |
| 2025-08-12 |
Volpone John |
Officer |
Unknown |
- |
- |
- |
- |
| 2025-08-12 |
Volpone John |
President |
RSU Award |
1,609,873 |
$1.42 |
$2.29M |
1,609,873 |
| 2025-06-09 |
Wyzga Michael S |
Director |
RSU Award |
1,500 |
- |
- |
5,555 |
| 2025-06-09 |
Mcgirr David W J |
Director |
RSU Award |
1,500 |
- |
- |
4,722 |
| 2025-06-09 |
Bridger Gary |
Director |
RSU Award |
1,500 |
- |
- |
4,722 |
| 2025-06-09 |
Stewart Murray |
Director |
RSU Award |
1,500 |
- |
- |
7,883 |
| 2025-06-09 |
De Craecker Francoise |
Director |
RSU Award |
1,500 |
- |
- |
4,722 |
| 2025-06-09 |
Woods Keith |
Director |
RSU Award |
1,500 |
- |
- |
6,000 |
| 2025-05-20 |
Thoren Natasha Fay |
Chief Legal Officer |
Unknown |
8,166 |
$32.70 |
$267.03K |
- |
| 2025-05-20 |
Thoren Natasha Fay |
Chief Legal Officer |
RSU Award |
3,333 |
- |
- |
9,462 |
| 2025-05-16 |
Baldry Mark |
Chief Commercial Officer |
Informative Buy |
1,032 |
$2.48 |
$2.56K |
25,337 |
| 2025-05-16 |
Baldry Mark |
Chief Commercial Officer |
RSU Award |
1,032 |
$2.48 |
$2.56K |
25,337 |
| 2025-02-12 |
Baldry Mark |
Chief Commercial Officer |
RSU Award |
600,000 |
- |
- |
729,173 |
| 2025-02-12 |
Mostafa Adam S. |
Chief Financial Officer |
RSU Award |
850,000 |
- |
- |
850,000 |
| 2025-02-12 |
Ragan Paula |
President and CEO |
RSU Award |
2,250,000 |
- |
- |
3,337,386 |
| 2025-02-12 |
Arbet-engels Christophe |
Chief Medical Officer |
RSU Award |
850,000 |
- |
- |
864,207 |
| 2025-02-12 |
Dibiase Mary |
Chief Operating Officer |
RSU Award |
650,000 |
- |
- |
1,140,980 |
| 2025-01-24 |
Baldry Mark |
Chief Commercial Officer |
Informative Sell |
29,159 |
$0.45 |
$13.24K |
94,123 |
| 2025-01-24 |
Mostafa Adam S. |
Chief Financial Officer |
Informative Sell |
74,773 |
$0.45 |
$33.95K |
- |
| 2025-01-24 |
Ragan Paula |
President and CEO |
Informative Sell |
76,473 |
$0.45 |
$34.72K |
1,087,386 |
| 2025-01-24 |
Arbet-engels Christophe |
Chief Medical Officer |
Informative Sell |
11,624 |
$0.45 |
$5.28K |
14,207 |
| 2025-01-24 |
Dibiase Mary |
Chief Operating Officer |
Informative Sell |
22,258 |
$0.45 |
$10.09K |
490,980 |
| 2025-01-23 |
Baldry Mark |
Chief Commercial Officer |
RSU Award |
74,773 |
- |
- |
123,282 |
| 2025-01-23 |
Mostafa Adam S. |
Chief Financial Officer |
RSU Award |
74,773 |
- |
- |
74,773 |
| 2025-01-23 |
Ragan Paula |
President and CEO |
RSU Award |
169,940 |
- |
- |
1,163,859 |
| 2025-01-23 |
Arbet-engels Christophe |
Chief Medical Officer |
RSU Award |
25,831 |
- |
- |
25,831 |
| 2025-01-23 |
Dibiase Mary |
Chief Operating Officer |
RSU Award |
61,178 |
- |
- |
513,238 |
| 2024-11-15 |
Baldry Mark |
Chief Commercial Officer |
Informative Buy |
13,404 |
$0.34 |
$4.6K |
129,173 |
| 2024-11-15 |
Ragan Paula |
President and CEO |
Informative Sell |
31,897 |
$0.39 |
$12.58K |
993,919 |
| 2024-10-15 |
Ragan Paula |
President and CEO |
Informative Sell |
31,897 |
$0.56 |
$17.93K |
1,025,816 |
| 2024-10-07 |
Baldry Mark |
Chief Commercial Officer |
Informative Sell |
11,127 |
$0.58 |
$6.51K |
48,509 |
| 2024-10-07 |
Mostafa Adam S. |
Chief Financial Officer |
Informative Sell |
230,645 |
$0.55 |
$126.9K |
- |
| 2024-10-07 |
Ragan Paula |
President and CEO |
Informative Sell |
239,436 |
$0.55 |
$131.52K |
1,057,713 |
| 2024-10-07 |
Taveras Arthur |
Chief Scientific Officer |
Informative Sell |
76,920 |
$0.56 |
$43.31K |
388,026 |
| 2024-10-07 |
Dibiase Mary |
Chief Operating Officer |
Informative Sell |
67,695 |
$0.57 |
$38.33K |
452,060 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
